Holen Sie sich die Stockscreener-App
136.00
5.56%
-8.00
Handel nachbörslich:
138.80
2.80
+2.06%
Schlusskurs vom Vortag:
$144.00
Offen:
$142.63
24-Stunden-Volumen:
4.56M
Relative Volume:
1.60
Marktkapitalisierung:
$29.32B
Einnahmen:
$606.42M
Nettoeinkommen (Verlust:
$-1.28B
KGV:
-21.24
EPS:
-6.403
Netto-Cashflow:
$-997.58M
1W Leistung:
-2.51%
1M Leistung:
-17.53%
6M Leistung:
-6.05%
1J Leistung:
+72.65%
1-Tages-Spanne:
$135.73
$143.60
1-Wochen-Bereich:
$135.73
$147.38
52-Wochen-Spanne:
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Compare INSM vs VRTX, REGN, ALNY, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
136.00 | 29.32B | 606.42M | -1.28B | -997.58M | -6.403 |
VRTX
Vertex Pharmaceuticals Inc
|
454.00 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
732.87 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.17 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
663.93 | 41.09B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
275.28 | 30.56B | 5.36B | 287.73M | 924.18M | 2.5229 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Fortgesetzt | Jefferies | Buy |
| 2026-01-28 | Eingeleitet | Barclays | Overweight |
| 2026-01-23 | Eingeleitet | Roth Capital | Buy |
| 2025-12-19 | Fortgesetzt | Truist | Buy |
| 2025-12-04 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-28 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story - The Motley Fool
How Insmed (INSM) Is Rewriting Its Story Around Brinsupri And 2026 Expectations - Yahoo Finance
Insmed chair and CEO Lewis sells $1.5M in shares By Investing.com - Investing.com Canada
Insmed (INSM) poised for 2026 upside with potential $1.3B Arikayce sales boost, Roth/MKM initiates buy - MSN
Form 144 INSMED INC For: 5 March By Investing.com - Investing.com Australia
Insmed chair and CEO Lewis sells $1.5M in shares - Investing.com
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 10,699 Shares of Stock - MarketBeat
INSMED (NASDAQ: INSM) CEO exercises options and sells 10,699 shares under 10b5-1 plan - Stock Titan
Brensocatib Approval Gives Insmed New Growth Pillar And Valuation Gap - Yahoo Finance
INSM Stock Price, Quote & Chart | INSMED INC (NASDAQ:INSM) - ChartMill
William Lewis reports share sales at INSM (NASDAQ: INSM) in Form 144 - Stock Titan
Artisan Small Cap Fund Sold Insmed (INSM) on Valuation Consideration - Yahoo Finance
Novo Holdings A S Sells 480,000 Shares of Insmed, Inc. $INSM - MarketBeat
Long Focus Capital Management LLC Sells 182,200 Shares of Insmed, Inc. $INSM - MarketBeat
Millennium Management LLC Has $336.42 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Position Decreased by Jain Global LLC - MarketBeat
Fred Alger Management LLC Has $13.54 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Granahan Investment Management LLC Reduces Holdings in Insmed, Inc. $INSM - MarketBeat
INSM: Jefferies Upgrades Insmed to Buy, Sets Price Target at $22 - GuruFocus
Insmed (NASDAQ:INSM) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
HighVista Strategies LLC Has $7.19 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Holocene Advisors LP Trims Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM is Darwin Global Management Ltd.'s Largest Position - MarketBeat
506,245 Shares in Insmed, Inc. $INSM Bought by Bank of Nova Scotia - MarketBeat
Aquatic Capital Management LLC Has $10.99 Million Stake in Insmed, Inc. $INSM - MarketBeat
Eventide Asset Management LLC Sells 191,387 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stake Increased by Brevan Howard Capital Management LP - MarketBeat
Cinctive Capital Management LP Buys 33,307 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Reduced by Baker BROS. Advisors LP - MarketBeat
Algert Global LLC Purchases 62,802 Shares of Insmed, Inc. $INSM - MarketBeat
Suvretta Capital Management LLC Has $31.36 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Van ECK Associates Corp - MarketBeat
Landscape Capital Management L.L.C. Purchases Shares of 28,194 Insmed, Inc. $INSM - MarketBeat
Russell Investments Group Ltd. Has $23.97 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Bought by Swiss National Bank - MarketBeat
Insmed, Inc. $INSM Stock Position Trimmed by Franklin Resources Inc. - MarketBeat
First Trust Advisors LP Purchases 193,254 Shares of Insmed, Inc. $INSM - MarketBeat
MDA 2026: Insmed launches Phase 1 trial of INS1202 gene therapy for ALS - ALS News Today
Atika Capital Management LLC Makes New Investment in Insmed, Inc. $INSM - MarketBeat
FOMO Trade: Is Insmed Incorporated stock a buy or sellEarnings Summary Report & Expert Verified Movement Alerts - baoquankhu1.vn
Insmed at Leerink Global Healthcare Conference: Strategic Insights - Investing.com India
Insmed at Leerink Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Nigeria
INSM: ENCORE and BRINSUPRI drive growth as new pipeline assets advance toward major milestones - TradingView
Capital International Investors Raises Stock Position in Insmed, Inc. $INSM - MarketBeat
INSM stock jumps on 2025 preliminary sales, 2026 goals announced - MSN
Fieldview Capital Management LLC Purchases Shares of 20,229 Insmed, Inc. $INSM - MarketBeat
Rhenman & Partners Asset Management AB Has $18.99 Million Stake in Insmed, Inc. $INSM - MarketBeat
Neo Ivy Capital Management Has $1.40 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Neuberger Berman Group LLC Raises Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Victory Capital Management Inc. Boosts Position in Insmed, Inc. $INSM - MarketBeat
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):